5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | SELL | SELL | SELL | NEUTRAL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 3.35▲ | 3.37▼ | 3.38▼ | 3.41▼ | 3.40▼ |
MA10 | 3.36▲ | 3.35▲ | 3.35▲ | 3.52▼ | 3.11▲ |
MA20 | 3.36▲ | 3.35▲ | 3.41▼ | 3.37▼ | 3.14▲ |
MA50 | 3.36▲ | 3.39▼ | 3.41▼ | 3.01▲ | 3.41▼ |
MA100 | 3.34▲ | 3.43▼ | 3.53▼ | 3.24▲ | 3.97▼ |
MA200 | 3.40▼ | 3.50▼ | 3.19▲ | 3.45▼ | 3.77▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.002▼ | 0.008▲ | -0.001▼ | -0.032▼ | 0.088▲ |
RSI | 52.338▲ | 49.351▼ | 47.042▼ | 52.620▲ | 51.138▲ |
STOCH | 29.464 | 79.114 | 63.483 | 23.732 | 67.758 |
WILL %R | -37.500 | -20.930▲ | -47.692 | -76.871▼ | -29.792 |
CCI | -17.488 | 43.151 | -28.595 | -119.001▼ | 84.713 |
Thursday, June 12, 2025 08:07 AM
Piper Sandler sets $78 target on Tvardi, seeing 150%+ upside based on TTI-101's potential. Tvardi has cash runway into H2 2026, covering two Phase 2 readouts in IPF and HCC. Get ahead of Wall ...
|
Tuesday, June 10, 2025 05:00 PM
Kurt Hallead, the VP-Treasurer & IR of $TTI, bought 72,633 shares of the company on 06-11-2025 for an estimated $246,225. This trade was reported by Quiver ...
|
Wednesday, May 28, 2025 05:48 PM
Cara Therapeutics (NASDAQ:CARA), Inc., a biopharmaceutical company with a market capitalization of $21.53 million, announced today that it has successfully regained compliance with the Nasdaq's ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/07/25 | 3.31 | 3.41 | 3.195 | 3.365 | 2,203,260 |
30/06/25 | 3.52 | 3.535 | 3.355 | 3.36 | 929,271 |
27/06/25 | 3.47 | 3.54 | 3.39 | 3.53 | 6,490,900 |
26/06/25 | 3.31 | 3.47 | 3.25 | 3.46 | 1,507,000 |
25/06/25 | 3.43 | 3.47 | 3.31 | 3.32 | 1,135,200 |
24/06/25 | 3.38 | 3.47 | 3.34 | 3.45 | 991,200 |
23/06/25 | 3.73 | 3.75 | 3.40 | 3.41 | 1,855,900 |
20/06/25 | 3.81 | 3.82 | 3.62 | 3.67 | 1,812,500 |
18/06/25 | 3.90 | 3.93 | 3.71 | 3.74 | 1,129,704 |
17/06/25 | 3.59 | 3.93 | 3.58 | 3.85 | 2,349,985 |
|
|
||||
|
|
||||
|
|